Phibro Animal Health reported $567.14M in Stock for its fiscal quarter ending in September of 2026.





Stock Change Date
Align Technology USD 212.24M 2.7M Jun/2026
ANI Pharmaceuticals USD 136.41M 6.74M Sep/2026
Aurora Cannabis CAD 187.54M 12.47M Jun/2026
Bristol-Myers Squibb USD 2.7B 33M Sep/2026
Canopy Growth CAD 107.46M 3.06M Jun/2026
Corcept Therapeutics USD 11.91M 1.28M Sep/2026
Eli Lilly USD 18.19B 1.4B Sep/2026
Henry Schein USD 2.05B 9M Sep/2026
Idexx Laboratories USD 390.87M 705K Sep/2026
Knight Therapeutics CAD 95.4M 2.91M Mar/2024
Merck USD 6.16B 43M Sep/2026
Nektar Therapeutics USD 14.46M 1.78M Jun/2024
Pacira USD 3.83B 3.69B Sep/2026
Phibro Animal Health USD 567.14M 32.26M Sep/2026
Prestige Brands USD 179.2M 11.01M Sep/2026
Supernus Pharmaceuticals USD 113.24M 6.22M Sep/2026
Zoetis USD 2.54B 38M Sep/2026